Indoor Harvest Corp. (OTCPK:INQD) announced the acquisition of a 60% controlling interest in Metabiogenix USA for $2.5 million in a combination of cash and common stock. During the close of the acquisition, Metabiogenix USA received a valuation of $8.9 million from the Japanese Medical Institute.

“This acquisition will provide Indoor Harvest an exclusive agreement to market and distribute the portfolio of Metabiogenix USA Nutraceuticals throughout the entire Western Hemisphere (North, South, and Central America), and Spain. Metabiogenix USA is on track for substantial growth and projecting revenues that could be as high as $20 million for FY2024” stated Leslie Bocskor, chairman & CEO of INQD. “Words cannot express the …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.